PainReform Ltd.
General ticker "PRFX" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $3.3M (TTM average)
PainReform Ltd. does not follow the US Stock Market performance with the rate: -24.6%.
Estimated limits based on current volatility of 3.6%: low 0.95$, high 1.02$
Factors to consider:
- Total employees count: 10 as of 2020
- Current price 36.5% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.61$, 6.11$]
- 2025-12-31 to 2026-12-31 estimated range: [0.87$, 3.21$]
Financial Metrics affecting the PRFX estimates:
- Positive: with PPE of -0.1 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -589.43 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Negative: -0.75 < Inventory ratio change, % of 0
- Negative: negative Industry operating income (median)
Short-term PRFX quotes
Long-term PRFX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.09MM | $0.00MM | $0.00MM |
| Operating Expenses | $8.96MM | $9.58MM | $14.67MM |
| Operating Income | $-8.87MM | $-9.58MM | $-14.67MM |
| Non-Operating Income | $0.09MM | $0.25MM | $0.09MM |
| Interest Expense | $0.06MM | $0.38MM | $0.01MM |
| R&D Expense | $4.42MM | $6.04MM | $11.71MM |
| Income(Loss) | $-8.78MM | $-9.34MM | $-14.58MM |
| Taxes | $0.01MM | $0.01MM | $0.01MM |
| Profit(Loss)* | $-8.79MM | $-9.34MM | $-14.59MM |
| Stockholders Equity | $11.02MM | $7.24MM | $1.82MM |
| Inventory | $7.82MM | $0.00MM | $0.00MM |
| Assets | $12.33MM | $9.93MM | $4.53MM |
| Operating Cash Flow | $-6.46MM | $-6.68MM | $-12.62MM |
| Capital expenditure | $0.01MM | $0.01MM | $0.01MM |
| Investing Cash Flow | $-6.01MM | $5.99MM | $-0.01MM |
| Financing Cash Flow | $0.00MM | $4.62MM | $8.86MM |
| Earnings Per Share** | $-197.92 | $-171.33 | $-32.16 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.